Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Vision board ideas for adults: how to create one that inspires real change
BY THE OPTIMIST DAILY EDITORIAL TEAM A vision board might look like a crafty throwback to childhood afternoons spent collaging. But don’t write it ...
Read MoreIndia’s social experiment: how paying women directly reshapes welfare, autono...
BY THE OPTIMIST DAILY EDITORIAL TEAM Across India, millions of women now receive a modest but unwavering deposit each month into their bank accounts. ...
Read MoreNew Zealand’s groundbreaking shift to renewables promises massive emiss...
New Zealand launched its most ambitious emissions reduction initiative to date in an incredible undertaking. The government announced a historic switch from coal to ...
Read MoreGoing for the goal: the impact of team sports on boosting young girls’ ...
In a pioneering study, the Here for Every Goal report demonstrates that team sports, particularly elite women's soccer (referenced from here on in this ...
Read More
